|
- OPDIVO® (nivolumab)
OPDIVO ® (nivolumab) is a prescription medicine used to treat a kind of skin cancer called melanoma It may be used alone in adults and children 12 years and older with Stage IIB, Stage IIC, Stage III or Stage IV melanoma to help prevent melanoma from coming back after it has been completely removed by surgery
- Subcutaneous Injection | OPDIVO® (nivolumab) + Qvantig™ (hyaluronidase . . .
Learn more about OPDIVO® (nivolumab) + Qvantig™ (hyaluronidase-nvhy) as a subcutaneous injection treatment option for your fight against cancer Please see Indication and Important Safety Information
- Frequently Asked Questions (FAQ) | OPDIVO® (nivolumab)
Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO® Please see Indication and Important Safety Information
- OPDIVO® Support Patient Resources | OPDIVO® (nivolumab)
Whether you're a new or continuing OPDIVO® (nivolumab) patient, find resources that can support you through a cancer diagnosis and during treatment Access helpful resources and find assistance for OPDIVO® patients here Please see Indication and Important Safety Information
- OPDIVO QVANTIG™ COULD BE YOUR ANSWER TO FASTER TREATME
doctor to discuss the most appropriate treatment for you OPDIVO Qvantig (nivolumab and hyaluronidase-nvhy) is FDA-approved, and may be an alternative option to ntravenous (IV) OPDIVO® (nivolumab) for certain patients It s given through a subcutaneous (under-the-skin) injection OPDIVO Qvantig received by injection could be an option for pe
- How This Treatment Works | OPDIVO® (nivolumab)
Learn how OPDIVO® (nivolumab) alone and OPDIVO® + YERVOY® (ipilimumab) in combination work with your immune system to fight cancer Ask your doctor if these immunotherapies may work for you Access treatment information for your cancer type Please see Indication and Important Safety Information
- Advanced Kidney Cancer | Clinical Trial Results - OPDIVO
See how OPDIVO® (nivolumab) + CABOMETYX® (cabozantinib) performed in a clinical trials for adults with previously untreated kidney cancer that has spread (advanced renal cell carcinoma or aRCC)
- Questions to ask your doctor - OPDIVO
If you’re considering either OPDIVO® or OPDIVO + YERVOY® (ipilimumab) as a treatment option, these questions can help you start a conversation with you doctor at your next appointment
|
|
|